相互作用
Dabigatran etexilate + Defibrotide
重症度: 併用禁忌
Dabigatran etexilate and Defibrotide: contraindicated interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Defibrotide has profibrinolytic activity and may enhance the bleeding risk of anticoagulants. Together with dabigatran this can cause serious hemorrhage.
この相互作用をわかりやすく説明すると
Dabigatran etexilate and Defibrotide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.
Dabigatran etexilate belongs to Cardiovascular; Defibrotide belongs to Cardiovascular.
なぜ起こるのか
Additive pharmacodynamic effects on hemostasis from thrombin inhibition and enhanced fibrinolysis.
対処法
Avoid concurrent use; hold dabigatran during defibrotide therapy as directed by the specialist team, considering renal function for washout timing.
薬剤師に尋ねること
- Is there an alternative to one of these two medicines for me?
- If both are essential, who is monitoring me and how often?
- Which symptoms mean I should stop and seek help straight away?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Dabigatran etexilateとDefibrotideの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を7日間無料でお試し。カード登録不要。
Dabigatran etexilateのその他の相互作用
Defibrotideのその他の相互作用
よくある質問
Can I take Dabigatran etexilate with Defibrotide?
MediHelp rates the interaction as contraindicated. Dabigatran etexilate and Defibrotide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Defibrotide has profibrinolytic activity and may enhance the bleeding risk of anticoagulants. Together with dabigatran this can cause serious hemorrhage.
How serious is the interaction between Dabigatran etexilate and Defibrotide?
MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use; hold dabigatran during defibrotide therapy as directed by the specialist team, considering renal function for washout timing.
What other medicines interact with Dabigatran etexilate?
MediHelp also lists interactions of Dabigatran etexilate with, for example, Ketorolac, Mifepristone, Abciximab. The full list is on the Dabigatran etexilate page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
